VISTA·RESEARCH™
How it worksThe LibraryResearchHeritageAboutTalk to the Desk
Research

Inquiries and essays

What the price assumes, and who would know. Each inquiry takes a timely investment idea, works out what the market price already assumes from the company's own filings, names the data nobody outside the company has, and says who could supply it.

Hypotheses we're testing

Hypothesis · 15 November 2026 · Planet Fitness and the Black Card
The Price of the Thing Most People Take
Planet Fitness said past Black Card price rises never cost it joins, then paused the next one. Did a free month turn the premium card into the beginners' door? A test frozen in advance reads the next increase.
Interviews under way
Hypothesis · 15 November 2026 · DraftKings Predictions and its sportsbooks
Who's on the Line
DraftKings says its prediction market brings new customers. Eight state regulators can show whether its own sportsbooks are losing share. A test frozen in advance reads it in September 2027.
Scoring September 2027
Hypothesis · 12 November 2026 · Pentair, Hayward and the pool dealers
Inventory or Exodus
Pentair's pool shipments fell 20.6 percent through September, and by its own estimates the whole fall was inventory. Did some dealers also leave for Hayward? A test sealed before publication answers from the 2027 annual reports.
Interviews under way

All inquiries

No. 21 · 14 November 2026 · Who keeps the tariff refund
The Dollar With a Name on It
Walmart and Costco said their tariff refunds would go into lower prices. Target and Best Buy announced nothing of the kind. We took each refund out of each company's margin and froze a test, settled by August 31, 2027, of whether the cuts end when the money does.
No. 20 · 12 November 2026 · Roblox's age check on chat
The Face at the Door
Roblox began asking players to show it their faces before they could chat. In two futures we built, about 80 percent of activity has passed the check by June 2027, yet the two sit about $514 million apart in a quarter's bookings. A test set down before the evidence is scored from the June 2027 quarter.
No. 19 · 1 November 2026 · Customer delays at Microvast and Photronics
Late, or Gone
When a supplier blames its customers' delays, is the money late or gone? Microvast's written-down storage units, Photronics' delayed chip designs, and five tests frozen for 2027.
No. 18 · 26 October 2026 · Phantom data centers and the price of a place in line
The Paper Railway
Exelon says it screened the speculative data center requests out. ComEd's agreements, four exits read by Hasselmann's fingerprint, Parliament's railway deposits of 1845, and six measures frozen for 2027.
No. 17 · 23 October 2026 · Chinese robots and who keeps the learning
Unitree Robotics: Should We Be Afraid, or Very Afraid?
China's best known humanoid maker sells cheap, profitable robots, mostly to labs, and the learning so far moves by sale and license. Teece's rule, NVIDIA holding both complements, the channel no filing shows, and six measures frozen for Unitree's first annual report.
No. 16 · 8 October 2026 · Bitcoin miners as AI landlords
The Power and the Glory
Bitcoin's halving cut what a mining megawatt earns by more than half, and AI tenants now pay more to rent a miner's powered site than mining takes in. Who keeps the profit, what the switch is worth, how the market noticed, and a dated test of the rent.
No. 15 · 8 October 2026 · Being watched, from the nursery to the quarter-end
The Sprint to the Piano
A boy who ran to the piano when he heard his parents come home became a father who runs to the nursery. The math of being watched, from cleaner fish to fund managers, and a dated test of quarter-end window dressing.
No. 14 · 7 October 2026 · Coinbase, USDC and the income on idle money
What's in a Name
Coinbase's subscription and services line is 48% of its net revenue, and the name suggests steady fees. Most of it is two bets: one on the price of crypto, which it shares with trading, and one on short-term interest rates.
No. 13 · 7 October 2026 · Friction, wear and who keeps the saving
There's the Rub
When a better oil or a sensor makes a machine last longer, the customer keeps most of the saving, and the parts seller earns more from the failure than from preventing it. SKF, Fuchs and the Lubricant Maker's Dilemma, read with a model of the bargain.
No. 12 · 6 October 2026 · Moats, imitation and the chase
The Sincerest Flattery
The more a lead is worth, the harder rivals run to close it, so the leads that last are not always the best ones. Ford, Novo Nordisk, NVIDIA and the price of AI, read with a small model of the chase.
No. 11 · 6 October 2026 · NextEra, Dominion and Virginia
The Price of Consent
NextEra is buying Dominion, and Virginia must consent. Nash's bargaining model and Schelling's test of a threat say Virginia will get more and NextEra will pay; per share, the bill is smaller than the market fears.
No. 10 · 5 October 2026 · Jewelers, gold prices and the hedge
The Lighter Ring
When gold climbs, jewelers put less of it in each piece, and a hedge bought for last year's ring can grow too big for this year's. Signet, Pandora and Chow Tai Fook, read against the arithmetic of karats, hedges and restocking cash.
No. 9 · 5 October 2026 · CoreWeave, AI chips and how long they earn
The Second Rental
Critics say AI chips are spent in three years; the accounts say six. A model of a data center with no power to spare shows old chips are retired late, CoreWeave's six-year books ask little of a chip's second rental, and its share price asks a great deal more.
No. 8 · 4 October 2026 · GRAIL, the NHS-Galleri trial and Medicare
The Sieve and the Clock
GRAIL's Galleri blood test missed its trial's main goal, won an FDA panel's vote, and its stock now stands above where it was before the miss. A model of the trial explains the miss; the new Medicare law covers only people under 65 on January 1, 2029, one birth year at a time; and the price needs Cologuard's growth without Cologuard's coverage, or long odds on something larger. Three hypotheses for public markets follow.
No. 7 · 4 October 2026 · AI, growth and Joel Mokyr
The Method of Invention
Could AI be bigger than the Industrial Revolution? Mokyr's history says the test is whether it raises the rate at which useful knowledge grows, not only the level of output. The record so far shows a large general purpose technology, not yet a new method of invention, and the bond market's jump in long real yields owes more to the term premium than to growth. Four hypotheses for public markets follow.
No. 6 · 3 October 2026 · Distributed batteries and electrical constraint relief
The Stove That Buys Time
A battery inside a kitchen range sells time before an electrical upgrade, and on the draft's own numbers the time is worth less than the battery, except in apartment kitchens no load controller can reach. On an AI campus the same equation runs the other way: what decides the case is the months a bridge pulls forward, not the bill it postpones.
No. 5 · 3 October 2026 · Advanced Micro Devices
Two Trillion, Divided
AMD now pays its largest new customers in its own shares as they buy its accelerators. At $633.91, a 12% annual return at thirty times earnings needs 2030 earnings per share about eight times 2025's; how many ways those earnings are divided decides almost as much.
No. 4 · 3 October 2026 · West Pharmaceutical Services
The Stopper Annuity
West's stoppers are written into the filings of the drugs they seal, which makes the business an annuity. At $364.98 the shares assume it keeps compounding for decades; the filings cannot say for how long.
No. 3 · 3 October 2026 · Schneider Electric, Siemens, Prysmian
After the Lights Come On
Europe's electrical champions are selling the equipment of a generation. At October 2 prices the shares assume the cash keeps compounding after the boom; the service annuity that would prove it is not yet in the filings.
No. 2 · 3 October 2026 · Veeva Systems
Moving Day
Every company on Veeva's original CRM must move by the end of 2029, and fourteen of the twenty largest drug makers are moving with Veeva. At $273.33, 15% annual growth in owner cash offers 8% to 9% a year; 10% needs 18.8% to 21% for nine years.
No. 1 · 3 October 2026 · Mondelez International
The Chocolate Truce
Cocoa is falling, and Mondelez should be the winner. At $58.19 the shares already assume a full recovery; whether the relief is kept depends on whether the world's chocolate makers keep the peace.

Essays

Essay · 17 November 2026
The Day Before Unblinding
A drug trial's rulebook dated one day before the data were unblinded, what luck does with five looks at the same patients, what a report of no cases weighs, and four questions to ask before an FDA decision.
Essay · 14 November 2026
The Prophet Who Hoped to Be Wrong
Two prophets in the Temple, 570 experts who agreed, and the arithmetic of what agreement is worth: how to grade a forecast, how few independent voices a crowd may hold, how a stake bends a number, and why the prophet who hoped he was wrong is the one to hear.
Essay · 15 October 2026
Luke 14, Served in Five Courses
One dinner at a Pharisee's house, served in five courses, and the arithmetic hidden in each: what it costs to be watched, which seat to take, whom to invite, how a full hall empties in four rounds and fills again from the hedges, and why a king with ten thousand men sends an envoy. For people who count for a living, and for anyone who has wondered whether the old book still has something to say to them.

Why I publish these

These inquiries are where I put the mathematical models I learned at Northwestern and the University of Chicago back to work, on questions from the day’s financial news. I write them with AI, openly: the idea and the judgment are mine, the models are catalogued in the Library, and every figure is computed in code and checked against its source. Each inquiry ends with the data still missing, which is where Vista’s primary research begins. Why I work this way: Time Regained.

I publish these inquiries for three reasons. The first is the pleasure of it: there is no better test of a model I have admired for decades than a live question with money on it. The second is to show what Vista does for its clients in private: a hypothesis worth testing, careful secondary research, the math written out, and conversations with the people who know, combined in one brief. The third is that the hypotheses are my own. I run my investment ideas through Vista’s research desk because I know what it can do, and what we find informs the investments of the Rosenzweig family office, proudly one of the smallest family offices in the world. When you read an inquiry, you are watching the method we use with our own money. That is also why every inquiry ends by saying what I own.

Inquiries are research, not recommendations. Vista never publishes what a share is worth or whether to own it; the decision belongs to the reader. Every inquiry sets down the tests that will judge it, and the scorecard grades each one when its checkpoint arrives.